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Background. During acute infection and inflammation, dramatic shifts in tissue metabolism are typical, thereby resulting in
profound tissue hypoxia. Therefore, we pursued the hypothesis, that tissue hypoxia may influence innate immune responses
by transcriptional modulation of Toll-like receptor (TLRs) expression and function. Methodology/Principal Findings. We
gained first insight from transcriptional profiling of murine dendritic cells exposed to hypoxia (2% oxygen for 24 h). While
transcript levels of other TLRs remained unchanged, we found a robust induction of TLR2 (2.3660.7-fold; P,0.05) and TLR6
(3.4661.56-fold; P,0.05). Additional studies in different cells types and cell-lines including human dendritic cells, monocytic
cells (MM6), endothelia (HMEC-1) or intestinal epithelia (Caco-2) confirmed TLR2 and TLR6 induction of transcript, protein and
function during hypoxia. Furthermore, analysis of the putative TLR2 and TLR6 promoters revealed previously unrecognized
binding sites for HIF-1, which were shown by chromatin immunoprecipitation to bind the pivotal hypoxia-regulating
transcription factor HIF-1alpha. Studies using loss and gain of function of HIF-1 confirmed a critical role of HIF-1alpha in
coordinating TLR2 and TLR6 induction. Moreover, studies of murine hypoxia (8% oxygen over 6 h) showed TLR2 and TLR 6
induction in mucosal organs in vivo. In contrast, hypoxia induction of TLR2 and TLR6 was abolished in conditional HIF-1a
mutant mice. Conclusions/Significance. Taking together, these studies reveal coordinated induction of TLR2 and TLR6
during hypoxia and suggest tissue hypoxia in transcriptional adaptation of innate immune responses during acute infection or
inflammation.
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INTRODUCTION
Microorganisms that invade a vertebrate host are initially
recognized by the innate immune system through germline-
encoded pattern-recognition receptors [1]. Innate defense mech-
anisms rely heavily on such signaling pathways to alert the
immune system of the presence of the invading pathogens. As a
group of pattern-recognition molecules, Toll-like receptors (TLRs)
have evolved into a central role during such responses. As such,
mammalian TLRs represent a family of at least 12 membrane
proteins that trigger innate immune responses through nuclear
factor-kB (NF-kB)-dependent and interferon (IFN)-regulatory
factor-dependent signalling pathways [2]. TLRs are evolutionarily
conserved molecules and were originally identified in vertebrates
on the basis of their homology with ‘‘Toll’’, a molecule that
stimulates the production of antimicrobial proteins in Drosophila
melanogaster [3]. Mammalian TLRs have been functionally
characterized and distinguished mainly on the basis of their
stimulation by different ligands [4]. As such, the TLR-family
members are pattern-recognition receptors (PRRs) that recognize
lipid, carbohydrate, peptide and nucleic-acid structures that are
broadly expressed by different groups of microorganisms [2]. In
addition to their role in innate immune responses during infection,
the recognition of endogenous ligands by TLRs is now thought to
have an important role also in the regulation of inflammation,
both in infectious and non-infectious diseases [2].
In this context, acute sites of inflammation or infection are
characterized by dramatic shifts in tissue metabolism [5]. These
changes include increased consumption of oxygen by residential or
recruited inflammatory cells, and diminished availability of oxygen
due to thrombosis or inflammation of the vascular support system,
resulting in profound hypoxia [6–8]. Such shifts in tissue
metabolism result, at least in part, from massive recruitment of
inflammatory cell types or pathogens [5,9,10]. As such, studies of
innate immune responses have found a central role of hypoxia–
elicited signaling pathways in inflammatory immune responses.
For example, a very elegant study of inflammatory response in
mice with conditional knockouts of the hypoxia responsive
transcription factor hypoxia inducible factor (HIF)-1a revealed
profound impairment of myeloid cell aggregation, motility,
invasiveness, and bacterial killing [11]. Taken together, these
studies demonstrate a role for HIF-1a in the direct regulation of
survival and function in the inflammatory microenvironment.
At the tissue and cellular level, hypoxia induces an array of
genes pivotal to survival in low oxygen states. As a global regulator
of oxygen homeostasis, the ab heterodimeric transcription factor
HIF-1 facilitates both oxygen delivery and adaptation to oxygen
deprivation [12]. HIF-1 is a member of the Per-ARNT-Sim (PAS)
family of basic helix-loop-helix (bHLH) transcription factors. HIF-
1 activation is dependent upon stabilization of an O2-dependent
degradation domain of the a subunit and subsequent nuclear
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cofactors such as CBP and its ortholog p300 [13]. Under
conditions of adequate oxygen supply, iron and oxygen dependent
hydroxylation of two prolines (Pro564 and Pro 402) within the
oxygen-dependent degradation domain (ODD) of HIF-1a initiates
the association with the von Hippel-Lindau tumor suppressor
protein (pVHL) and rapid degradation via ubiquitin-E3 ligase
proteasomal targeting [12]. A second hypoxic switch operates in
the carboxy terminal transactivation domain of HIF-1a ˜ Here,
hypoxia blocks the hydroxylation of asparagine-803 so facilitating
the recruitment of CBP/p300 [14]. When levels of oxygen fall
below a critical threshold (hypoxia), the lack of PHD substrate
(oxygen) results in the accumulation of HIF ˜a, which then
associates with HIF2b. The HIF heterodimer translocates to the
nucleus where it is made available to activate HIF-bearing gene
promoters. Genes induced by HIF-1 include those necessary for
cell, tissue and whole animal adaptive responses to hypoxia [12].
These proteins include enzymes involved in anaerobic metabo-
lism, the angiogenic cytokine vascular endothelial growth factor
(VEGF) and inducible nitric oxide synthase [12].
In the present study, we pursued the hypothesis that tissue
hypoxia–as occurs during inflammation or infection–may modu-
late PRR-dependent signaling pathways of the innate immune
system. For this purpose, we screened mammalian TLR
expression during normoxic or hypoxic conditions. Serendipitous-
ly, these studies revealed a central role of HIF-1 in the coordinated
induction of TLR2 and TLR6, which are known for their
functional interaction in the cellular response to different
microorganisms [15,16].
RESULTS
Modulation of TLR signaling by hypoxia
Sites of infection and inflammation are characterized by dramatic
shifts in metabolic supply and demand, thereby leading to
profound tissue hypoxia [5]. Given the association of hypoxia
with tissue-infections and the predominant role of TLR-signaling
in regulating host-cell responses during infections with human
pathogens [2], we pursued transcriptional responses of TLRs
during hypoxia. As first step in the line of these experiments, we
examined the influence of hypoxia on expressional levels of
mammalian TLRs (TLR1-9 and 11-13) in vitro, using a cellular
model of murine dendritic cells. For this purpose, we isolated
bone-marrow-derived dendritic cells (BMDCs) from C57BL/
66129SV mice and exposed them ex vivo to normoxia or
normobaric hypoxia (2% oxygen, 24h). Using real-time RT-PCR
analysis, we found selective induction of mRNA levels of TLR2
(2.36060.3810, P,0.05) and TLR6 (3.46060.7820, p,0.05) with
hypoxia exposure in comparison to normoxia (Fig. 1). In contrast,
transcript levels of other TLRs remained unchanged with hypoxia
exposure. Due to the fact that TLR10 expression has not been
detected in murine BMDCs [17] we studies modulation of TLR 10
transcript in human microvascular endothelia (HMEC-1) and
human intestinal epithelia (CaCo-2). These studies revealed no
changes of TLR10 transcript with hypoxia (data not shown).
Taken together, these studies show a robust and selective
induction of TLR2 and TLR6 coordinated by hypoxia.
Hypoxia induces TLR2 mRNA and protein and
enhances TLR2 signaling effects
Based on the above observation of coordinated induction of TLR2
and TLR6 with hypoxia, we next pursued additional details of
TLR2 induction with hypoxia using different cellular models.
Therefore, we exposed human dendritic cells (hDCs), monocytic
cells (MM6), endothelia (HMEC-1) and epithelia (Caco-2) over
indicated time periods to hypoxia (2% oxygen), isolated RNA and
performed real-time RT-PCR to determine TLR2 transcript levels.
Consistent with our studies of murine dendritic cells, we found a
robust induction of TLR2 transcript in all examined cells (Figure 2
A, B). For example, real-time RT-PCR analysis revealed prominent
induction of TLR2 mRNA expression in hDCs (3.01260.3002,
p,0.01)and MM6 cells (1.81260.4875,p,0.05) after 24h exposure
to hypoxia. Similarly, TLR2 transcript was significantly elevated
after12 hofhypoxiaexposureofHMEC-1(2.17060.2944,p,0.05)
orCaco-2cells(1.54360.1009,p,0.05).Wenext pursued induction
of TLR2 protein levels by Western blot analysis. For this purpose,
HMEC-1 were grown to full confluency and exposed to hypoxia (0,
24, 48 and 72 h; pO2 20 torr). Indeed, we found increases of TLR2
protein in HMEC-1 after different time points of hypoxia exposure
(Fig. 2C). As next step, we studied functional consequences of TLR2
induction by hypoxia. Previous studies had shown specific activation
of TLR2 by N-Palmitoyl-bis(palmitoyloxy)-propyl-cysteinyl-seryl-
Lys4 (P3C) leading to TLR2-signaling dependent activation of NF-
kB and the production of pro-inflammatory cytokine IL6 [18]. For
that purpose we stimulated normoxic or post-hypoxic HMEC-1 cells
(48 h at 2% oxygen) with the TLR2 agonist P3C and measured IL6
secretion into the supernatant. These studies revealed that TLR2-
dependent release of IL6 was dramatically enhanced in post-hypoxic
HMEC-1 (Fig. 2D, p,0.01 with 100 ng/ml P3C). Taken together
these studies confirm that TLR2 transcript, protein and function are
induced by hypoxia.
Figure 1. Influence of hypoxia on TLR mRNA expression in murine
dendritic cells. Isolated murine bone-marrow-derived dendritic cells
(BMDCs) were exposed to normoxia or hypoxia for 24 hours. Total RNA
was isolated, and quantitative mRNA levels of TLR1-9 and TLR11-13
were assessed by real-time RT-PCR. Data were calculated relative to ß-
actin and expressed as fold change relative to normoxia6SEM and
transcript levels in normoxic BMDCs were normalized to 1. Results are
derived from three different experiments (*p,0.05, significant differ-
ences from normoxia).
doi:10.1371/journal.pone.0001364.g001
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After having shown induction of TLR2 with hypoxia, we next
studied additional details of TLR6 induction during hypoxia. In
fact, TLR6 can function as co-receptor and heterodimerizes with
TLR2 to form preexisting cell surface receptors on different cell
types [19]. Such TLR2/TLR6 complexes play an important role
in innate immune responses by recognizing microbial compounds
including lipoteichoic acids from gram-positive bacteria [20] or
fungal zymosan [21]. In order to confirm TLR6 inducibility by
hypoxia, we exposed human DCs, MM6, HMEC-1 or Caco-2
epithelia to hypoxia (2% oxygen) and measured changes in TLR6
transcript level by real-time RT-PCR. Similar to the above
Figure 2. TLR2 transcript, protein and function during hypoxia. A and B, Quantification of TLR2 transcript levels in freshly purified blood DCs, MM6
cells, confluent HMEC-1 monolayers and confluent Caco-2 monolayers. Cells were exposed to normoxia or hypoxia over indicated time periods. Total
RNA was isolated and TLR2 mRNA levels were determined by real-time RT-PCR. Data were calculated relative to ß-actin and expressed as fold change
relative to normoxia6SEM, where transcript levels in normoxic cells were normalized to 1. Results are derived from three different experiments
(*p,0,05, significant differences from normoxia). C, Confluent HMEC-1 cells were grown to confluence and exposed to indicated periods of hypoxia.
Results depict representative TLR2 Western blot from three separate experiments. The same blot was probed for ß-actin expression as a control for
protein loading. D, Similar amounts of HMEC-1 were grown to confluence in 24-well plates and indicated concentrations of specific TLR2 agonist
(P3C) were added before exposure to hypoxia or normoxia for 24 h. After 24 h, generation of IL6 was measured by ELISA in the cell supernatant. Data
are mean6SEM from 3 separate replicates. *, significant differences from untreated cells (p,0.001); #, significant differences from normoxia and
untreated cells (p,0.01).
doi:10.1371/journal.pone.0001364.g002
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confirmed hypoxia induction of TLR6 in all cell lines studied
(Figure 3A and B). For example, TLR6 transcript levels were
dramatically elevated following 24 h of hypoxia exposure in Caco-
2 cells (4.08060.4446, p,0.01). We next verified these findings on
a protein level by measuring TLR6 expression by Western blot
analysis. Here, we exposed confluent HMEC-1 monolayers to
hypoxia over 0 to 72h to hypoxia. Consistent with our studies of
TLR6 transcript, we found a robust induction of TLR6 protein
with hypoxia (Figure 3C). As next step we studied TLR signaling
effects during normoxia or hypoxia. Here, we used a specific
ligand for the TLR2/TLR6 complex (FSL-1, range 1–100 ng/ml)
and measured IL6 concentration in the HMEC-1 pre-exposed to
normoxia or 24 h of hypoxia (2% oxygen). In fact, FSL-1
Figure 3. TLR6 transcript, protein and function during hypoxia. A and B, Quantification of TLR6 transcripit levels in freshly purified blood DCs, MM6
cells, confluent HMEC-1 monolayers and confluent Caco-2 monolayers. Cells were exposed to normoxia and hypoxia for indicated time points. Total
RNA was isolated and TLR6 mRNA levels were determined by real-time RT-PCR. Data were calculated relative to ß-actin and expressed as fold change
relative to normoxia6SEM, where transcript levels in normoxic cells were normalized to 1. Results are derived from three different experiments. *,
significant differences from normoxic cells (p,0.01). C, Confluent HMEC-1 cells were grown to confluence and exposed to indicated periods of
hypoxia. Result depicts a representative TLR6 Western blot from three separate experiments. The same blot was probed for ß-actin expression as a
control for protein loading. D, Same amount of HMEC-1 cells were grown to confluence in 24-well plates. Cells were then stimulated with TLR2/6
agonist (FSL-1) at the indicated concentrations and exposed to hypoxia or normoxia for 24 h. After 24 h, generation of IL6 was measured by ELISA in
the cell supernatant. Data are mean6SEM from 3 separate replicates. *, significant differences from untreated cells (p,0.05); #, significant differences
from normoxia and untreated cells (p,0.05).
doi:10.1371/journal.pone.0001364.g003
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hypoxic HMEC-1 (Fig. 3D), showing that hypoxia enhances
signaling through the TLR2/6 complexes. These findings
confirms induction of TLR6 transcript, protein and function by
ambient hypoxia.
Role of hypoxia inducible factor (HIF)-1 in TLR2
regulation
In an attempt to gain specific insight into the mechanisms of
TLR2 induction, we began examining induction pathways from
hypoxia response genes. In the course of our experiments, we
identified two previously unappreciated HIF-1 binding sites in the
TLR2 gene promoter (DNA consensus motif 59-CCGTG-39
located at positions –54 to –58 and -61 to -65 relative to the
major transcription start site, Fig. 4A) [22]. To study a functional
contribution of HIF-1a in hypoxia induction of TLR2, we next
pursued HIF-1 loss and gain of function. As shown in Figure 4B,
baseline transcript levels are significantly repressed and hypoxia
inducibility of TLR2 transcript is attenuated when using a
previously characterized HMEC-1 line with stable siRNA
repression of HIF-1a compared to control transfected cells [23].
In addition, we studied TLR2 expression in a previously
characterized HMEC-1 line with oxygen stable overexpression
of HIF-1 [23]. As shown in Figure 4, normoxic expression of HIF-
1a is associated with dramatic increases of TLR2 transcript
(35.7669-fold increase, P,0.001). These findings could be
confirmed on a protein level by Western blot analysis (Fig. 4D).
Next, we used the HIF-1 activator dimethyloxalylglycine (DMOG,
a non specific inhibitor of prolylhydroxylases) [24,25]. Similar to
HIF-overexpression, pretreatment of HMEC-1 with DMOG was
associated with induction of TLR2 transcript levels (Figure 4E). As
last step, we determined whether this region of the TLR2
promoter binds HIF-1a. For these purposes, we used chromatin
immunoprecipitation (ChIP) to study HIF-1a binding in live cells.
As shown in Figure 4F, ChIP analysis of nuclei derived from
HMEC-1 cells revealed a prominent band in hypoxic but not
normoxic samples. No bands were evident in beads only or control
IgG immunoprecipitates, and input samples (preimmunoprecipi-
tation) revealed the predictable band under conditions of both
hypoxia and normoxia. Such results indicate that hypoxia induces
HIF-1a binding to the TLR2 promoter region. Together, these
results suggest that TLR2 induction by hypoxia is mechanically
determined, at least in part, by HIF-1.
HIF-1a in TLR6 induction during hypoxia
Similar to our studies of mechanisms of TLR2 induction by
hypoxia, we next attempted translational mechanisms of TLR6
induction during hypoxia. Similar to TLR2, we identified a
previously unrecognized binding site for HIF-1 in the putative
TLR6 gene promoter (DNA consensus motif 59-CCGTG-39
located at positions –502 to –506 relative to the transcription
start site, Fig. 5A). Consistent with our studies of TLR2, HIF-1 loss
and gain of function studies suggest a functional role of HIF-1a in
TLR 6 induction. As shown in Figure 5B, hypoxia inducibility of
TLR6 transcript is attenuated in HMEC-1 with stable siRNA
repression of HIF-1a, while normoxic overexpression of HIF-1a
(Figure 5C and D) or DMOG treatment (Figure 5E) is associated
with increased TLR6 levels. Finally, ChIP analysis of the putative
TLR6 promoter confirmed HIF-1a binding to the promoter
region during hypoxia (Figure 5F). Taken together these results
suggest HIF-1 in coordination of TLR2 and TLR6 induction by
hypoxia.
TLR2 and TLR6 are induced during ambient hypoxia
in vivo
To confirm hypoxia induction of TLR2 and TLR6 in vivo, we
utilized a previously described murine model of ambient hypoxia
[26–30]. For this purpose, we exposed C57BL/6 mice over 6h to
ambient hypoxia (8% oxygen), and examined TLR2 and TLR6
transcript levels in mucosal organs including the colon, liver and
lungs. As shown in Figure 6A (TLR2) and 6B (TLR6), real-time
PCR analysis revealed a significant increase of TLR2 and TLR6
transcript in all three examined organs. In addition, immunohis-
tochemical staining of sections of lung tissues confirmed TLR2
(Figure 7A) and TLR6 (Figure 7B) induction in vivo. Taken
together, these findings indicate that induction of TLR2 and
TLR6 also occurs during ambient hypoxia in vivo.
Role of HIF-1a in TLR2 and TLR6 expression in vivo As
last step in the line of these experiments, we extended these
findings of HIF-1–mediated induction of TLR2 and TLR6
expression into a genetic in vivo model. Here, we examined the
influence of hypoxia on TLR2 and TLR6 transcript levels in
intestinal epithelia derived from conditionally gene-targeted HIF-
1a mice, in which intestinal epithelia lack detectable HIF-1a
expression in .70% of cells [31]. As show in Figure 8A and 8B,
TLR2 and TLR6 levels in mice expressing wild-type HIF-1a
showed a normal pattern of hypoxia-associated induction of TLR2
and TLR6. Consistent with our hypothesis that HIF-1
transcriptionally induces TLR2 and TLR6, real-time PCR
analysis revealed abolished induction of TLR2 and TLR6
transcript levels in intestinal epithelial derived from Hif1a
mutant animals. Taken together, such findings support our in
vitro findings and indicate the likelihood that HIF-1 directly
regulates murine TLR2 and TLR6 expression.
DISCUSSION
Sites of inflammation and infection are characterized by significant
changes in metabolic supply and demand. Such shifts frequently
result in inflammation-associated tissue hypoxia. Due to the
central role of the TLR-signaling system in the regulation of innate
immune responses, both in infectious and non-infectious diseases
[2], we pursued transcriptional effects of hypoxia on TLR
expression patterns. A screen of mammalian TLRs for hypoxia
responsiveness revealed a selective and robust induction of TLR2
and TLR6. Additional studies in different cellular models
(dendritic cells, monocytes, endothelia or epithelia) consistently
confirmed hypoxia-induction of TLR2 and TLR6. Using ChIP
assays, cellular models of HIF-loss and gain of function as well as
murine genetic models we could mechanistically determine HIF-
1a in the coordination of this response. Taken together, these
studies reveal modulation of TLR-dependent immune responses
by hypoxia and confirm previous studies on a central role of HIF
in the regulation of innate immunity [5,11,31–34].
Serendipitously, our studies revealed a coordinated induction of
TLR2 and TLR6 by hypoxia, as both receptors owe each other a
close functional relationship. In fact, a very elegant study on the
coordination of TLR responses revealed that TLR2 and TLR6,
together coordinate macrophage activation by Gram-positive
bacteria and the yeast cell-wall particle, zymosan [21]. In fact,
TLR6 and TLR2 are both recruited to the macrophage
phagosome, where they recognize peptidoglycan, a Gram-positive
pathogen component. By contrast, TLR2 recognizes another
component, bacterial lipopeptide, without TLR6. The require-
ment for TLR cooperation is supported by the finding that TLR2
needs a partner to activate tumor necrosis factor-alpha production
in macrophages. As such, these studies revealed that TLR2 forms
TLR Signaling during Hypoxia
PLoS ONE | www.plosone.org 5 December 2007 | Issue 12 | e1364Figure 4. Influence of hypoxia inducible factor (HIF)-1a on TLR2 expression during hypoxia. A, Map of TLR2 promoter region showing positions of
the putative HIF binding sites and the binding site for NFkB and SP1 relative to the transcription start site (TSS). B, Stable transfected HMEC-1
monolayers containing either HIF-1a siRNA or control-siRNA were exposed to normoxia or hypoxia for indicated time points. Total RNA was isolated,
and 1 mg of RNA was transcribed into first strand cDNA. Relative expressional levels of TLR2 transcript were compared to normoxic controls by real-
time RT-PCR. Data were calculated relative to internal control gene (ß-actin), and are expressed as fold change over normoxia6SEM, *, significant
differences from normoxia and control cells (p,0.05). Results are derived from three different experiments in each condition. C, Total RNA of
normoxic monolayers of either wildtype (WT) or oxygen-stable HIF-1a expressing (HIF
+/+) HMEC-1 cells was isolated and real-time RT-PCR was
performed as described above. *, significant differences from wildtype cells (p,0.001). D, Western blot analysis of TLR2 protein of normoxic HMEC-1
wild type (WT) and oxygen-stable HIF-1a expressing (HIF+/+) cells. The same blot was probed for ß-actin expression as a control for protein loading. E,
HMEC-1 monolayers were treated with 1mM of dimethyloxalylglycine (DMOG), following measurement of TLR2 transcript levels by real-time RT-PCR
as described above. *, significant differences from untreated cells (p,0.001). F, ChIP assay was utilized to examine HIF-1a binding to the TLR2
promoter in normoxic and hypoxic HMEC-1 cells. Reaction controls included samples precipitated with protein G sepharose beads alone (beads),
immunoprecipitations using a nonspecific igG monoclonal antibody (IgG) and PCR performed using HMEC-1 DNA (input). An example of three
experiments is shown.
doi:10.1371/journal.pone.0001364.g004
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cytokine induction. The data suggest that TLRs sample the
contents of the phagosome independent of the nature of the
contents, and can establish a combinatorial repertoire to
discriminate among the large number of pathogen-associated
molecular patterns found in nature. As such, TLR2 seems to be
the most promiscuous TLR receptor able to recognize the most
diverse set of pathogen-associated patterns [19]. In fact, its
promiscuity has been attributed to its unique ability to hetero-
dimerize with other TLRs, particularly TLR1 and TLR6. Thus, it
Figure 5. Influence of hypoxia inducible factor (HIF)-1a on TLR6 expression during hypoxia. A, Map of TLR6 promoter region showing positions of
the putative HIF binding sites and the binding site for NFkB relative to the transcription start site (TSS). B, Stable transfected HMEC-1 monolayers
containing either HIF-1a siRNA or control-siRNA were exposed to normoxia or hypoxia for indicated time points. Total RNA was isolated, and 1 mgo f
RNA was transcribed into first strand cDNA. Relative expressional levels of TLR6 transcripts were compared to normoxic controls by real-time RT-PCR.
Data were calculated relative to internal control gene (ß-actin), and are expressed as fold change over normoxia6SEM, *, significant differences from
normoxia and control cells. Results are derived from three different experiments in each condition. C, Total RNA of normoxic monolayers of either
wildtype (WT) or oxygen-stable HIF-1a expressing (HIF
+/+) HMEC-1 cells was isolated and realt-time RT-PCR was performed as described above. *,
significant differences from wildtype cells. D, Western blot analysis of TLR6 protein of normoxic HMEC-1 wildtype (WT) and oxygen-stable HIF-1a
expressing (HIF+/+) cells. The same blot was probed for ß-actin expression as a control for protein loading. E, HMEC-1 monolayers were treated with
1mM of dimethyloxalylglycine (DMOG) for 24 hours. Afterwards transcript levels of TLR6 where quantified by real-time RT-PCR as described above. *,
significant differences from untreated cells. F, ChIP assay was utilized to examine HIF-1a binding to the TLR6 promoter in normoxic and hypoxic
HMEC-1 cells. Reaction controls included immunoprecipitations using a nonspecific igG monoclonal antibody (IgG) and PCR performed using HMEC-1
DNA (input). An example of three experiments is shown.
doi:10.1371/journal.pone.0001364.g005
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microbial ligands. In this context, a different study investigated
TLR2 cell surface heterotypic interactions in response to different
ligands as well as internalization and intracellular trafficking [19].
This study showed that TLR2/TLR6 heterodimers pre-exist and
are not induced by the ligand. Upon stimulation by the specific
ligand, these heterodimers are recruited within lipid rafts [19].
Thus, it is not surprising that transcriptional regulation of TLR2
and TLR6 are tightly linked together, while hypoxia-dependent
induction of TLR2 and TLR6 is a coordinated response under the
direct control of HIF-1a.
Only recently, many parallels between hypoxia and acute
infection and inflammation have become obvious. For example,
HIF-1 is essential for myeloid cell-mediated inflammation,
bactericidal capacity of phagocytes [35] and mice with conditional
knockouts of HIF-1 show profound impairment of myeloid cell
aggregation, motility, invasiveness, and bacterial killing [11].
Similarly, HIF-1 has been identified as key activator of the
inflammatory transcription factor NF-kB [36]. Similarly, recent
studies have also found a critical role of HIF-1 during bacterial
infections. For example, exposition of host cells to bacteria
(Bartonella henselae) results in HIF-1 activation and vascular
endothelial growth factor (VEGF) secretion in vivo and in vitro
[37]. Similar findings were reported when macrophages were
infected with group B streptococci [11,35]. These studies highlight
the role of HIF-1 in transcriptional regulation of infections with
human bacterial pathogens. Moreover, HIF plays a critical role in
inflammatory diseases, such as inflammatory bowel disease.
Colonic epithelial cells are anatomically positioned to provide a
selective barrier to luminal antigens and pathogens. Supported by
a complex vasculature, this physiologically crucial barrier is a
primary target for diminished blood flow and resultant tissue
hypoxia. A number of studies have indirectly implicated hypoxia
in mucosal inflammatory diseases such as colitis [38–41], and
recent studies in murine models identified the epithelium as the
central target of hypoxia during active inflammation [31]. As such,
the existence of mucosal hypoxia during inflammation could be
confirmed using 2-nitroimidazole compounds, which are retained
in the absence of adequate oxygen levels and can be visualized
using specific antibodies [42]. To further detail the physiologic
implications of epithelial HIF-1, a very elegant study by
Figure 6. Expression of TLR2 and TLR6 during ambient hypoxia in
vivo. A and B, Expression of TLR2 and TLR6 mRNA in normoxic or
hypoxic organs. Tissue of Colon, Liver and Lung where harvested from
mice after exposure to normoxia or normobaric hypoxia (8% O2, 92%
N2 for 6h). Total RNA was isolated, and quantitative mRNA levels of
TLR2 and TLR6 were assessed by real-time RT-PCR. Data were calculated
relative to ß-actin and expressed as fold change relative to normox-
ia6SEM and transcript levels in normoxic organs were normalized to 1.
Results are derived from six animals in each condition (*p,0.01,
significant differences from normoxia).
doi:10.1371/journal.pone.0001364.g006
Figure 7. Pulmonary immunohistochemistry for TLR2 and TLR6
during hypoxia. A and B, Lungs from mice exposed to normoxia or
normobaric hypoxia (8% O2, 92% N2 for 4h) were harvested, formalin-
fixed and paraffin-embedded. Sections were stained with antibodies for
TLR2 and TLR6 or isotype controls. This figure is representative of three
experiments in each condition.
doi:10.1371/journal.pone.0001364.g007
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targeted expression of either mutant HIF-1a (constitutive repres-
sion of HIF-1) or mutant von Hippel-Lindau gene [31]. Studies of
colitis in these mice revealed that epithelial ‘‘HIF-1 loss of
function’’ correlated with more severe clinical symptoms (mortal-
ity, weight loss, colon length, intestinal epithelial permeability),
whereas an increase in epithelial HIF-1 was protective for these
individual parameters.
At present, it remains unclear, whether HIF-1 represents a
protective host defense during inflammatory hypoxia, or is part of
a pathogenic response elicited by invading pathogens or excessive
inflammation. While recent studies in septic patients have
demonstrated an anti-protective effect of the HIF-1 regulated-
gene VEGF and suggest treatment of sepsis with VEGF-receptor
antibodies [43], other studies of inflammation and infection have
found a host-protective role of HIF-1. Such studies include a
protective role of HIF in murine colitis [31], adenosine-dependent
anti-inflammatory signaling pathways during hypoxia
[26,28,30,44–47], myeloid cell function [11] or bacterial capacity
of phagocytes [35]. With regard to the present findings of
coordinated induction of the TLR2/6 complex during hypoxia, it
remains unclear if such changes in TLR signaling patterns
represent a protective host-defense mechanism or can further
exacerbate infection and inflammation associated tissue damage.
However, recent studies suggesting a protective role of TLR2
signaling in experimental colitis [48]. In this study, oral treatment
of murine colitis with a TLR2 ligand significantly suppressed
mucosal inflammation and apoptosis by restoring tight junctional
integrity of the intestinal epithelium in vivo. In this context, it is
tempting to speculate that HIF-dependent induction of TLR2 and
TLR6 may be part of hypoxia-elicited innate protection during
epithelial inflammation and treatment with HIF-activators (such as
DMOG) may be protective during colitis via TLR2 induction and
signaling.
Taken together, the present studies reveal transcriptional-
dependent induction of TLR2 and TLR6 during hypoxia. Based
on ChIP analysis, cellular models of HIF-loss and gain of function
and additional genetic studies using conditional deletion of HIF-
1a, it appears likely that this response is coordinated by HIF-1a.A s
such, these studies highlight the central role of HIF-1 in the
transcriptional control of signaling pathways in innate immune
responses.
MATERIALS AND METHODS
Cell culture
Human microvascular endothelial cells (HMEC-1) were cultured
as described previously [23,26,28–30,49]. Human colonic epithe-
lial cells (Caco2) were grown and maintained as confluent
monolayers in 75 cm
2 growing flasks as previously described
[50]. MM6 cells were cultured as described previously [51]. Prior
to all experimental procedures, cultured cells were tested to rule
out contamination with Mycoplasma spp.. Human dendritic cells
(hDCs) were islotated from buffy coats of healthy blood donors as
described previously [52]. BMDCs were isolated and cultured as
described previously [53].
Transcriptional Studies
Transcript levels were quantified by real-time reverse transcrip-
tion-polymerase chain reaction (RT-PCR, iCycler; Bio-Rad
Laboratories, Hercules, CA), as described previously [26,28–
30,45,54]. Primer sets and PCR conditions are summarized in
Table 1.
Immunoblotting experiments
Immunoblotting experiments were performed as described
previously[44,45,47,49,54,55]. In short, HMEC-1 were grown to
confluence on 100-mm dishes and exposed to indicated experi-
Figure 8. Role of hypoxia inducible factor (HIF)-1 in TLR2 and TLR6
expression during hypoxia in vivo. Real-time RT-PCR analysis of murine
epithelial TLR2 and TLR6 mRNA in conditional HIF-1a mutant (HIF-/-) and
littermate control (WT) animals subjected to normoxia or hypoxia. Data
were calculated relative to ß-actin and are expressed as fold change over
normoxia6SEM, where transcript levels of control animals were
normalized to 1. *, significant differences from normoxic control animals
(p,0.05). Results are derived from 8 animals in each condition.
doi:10.1371/journal.pone.0001364.g008
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300 ml lysis buffer (150 mM NaCl, 25 mM Tris, pH 8.0, 5 mM
EDTA, 2% Triton X-100, and 10% mammalian tissue protease
inhibitor cocktail; Sigma-Aldrich), scraped and collected into
microfuge tubes. After spinning at 14,000 g to remove cell debris,
the pellet was discarded. Proteins were solublized in nonreducing
Laemmli sample buffer and heated to 70uC for 10 min. Samples
were resolved on a 12% polyacrylamide gel and transferred to
nitrocellulose membranes. The membranes were blocked for 1 h
at room temperature in TBS supplemented with 0.05% Tween 20
and 3% nonfat dry milk. The membranes were incubated either
with polyclonal rabbit anti-TLR2 (Acris, 2 mg/ml) or with
polyclonal rabbit anti-TLR6 (Abcam, 2 mg/ml) in PBS-T
supplemented with 0,05% Tween 20 and 3% nonfat dry milk
for 1h at 4uC over night, followed by 10 min washes in PBS-T.
The membranes were incubated in goat anti-rabbit (Pierce,
200 ng/ml) and conjugated to horseradish peroxidase for 1 h at
room temperature. The wash was repeated and proteins were
detected by enhanced chemiluminescence. To control for protein
loading, blots were stripped and re-probed for ß-actin using a
mouse monoclonal anti-human ß-actin antibody (Sigma-Aldrich).
TLR stimulation and IL6 ELISA
Similar numbers of HMEC-1 (,10
5 cells/well) were seeded in a
24-well plate and grown to confluence (2–3 days). After adding
new media, cell monolayers were stimulated with specific TLR
ligands (P3C, TLR2 ligand) from EMC microcollections GmbH,
Tuebingen, Germany; FSL-1 (synthetic, TLR2/6 ligand) from
InVivoGen, San Diego, CA, USA) with indicated ligand
concentrations (1, 10 and 100 ng/ml). Cells were exposed to
hypoxia and normoxia for 24h. Afterwards, supernatants were
harvested, centrifuged to remove cellular debris, and stored at
270uC until assayed by ELISA. Human IL-6 was quantified using
matched antibody pairs from R&D Systems in an ELISA
according to the manufactures instructions.
Chromatine immunoprecipitation (ChIP) assay
ChIP assays were performed using HMEC-1 subjected to
normoxia or hypoxia [30]. In brief, 2610
7 cells were fixed with
1% paraformaldehyde for 10 min. Cross-linking was stopped by
the addition of 125 mM glycine, and chromatin derived from
isolated nuclei was sheared using a F550 micro-tip cell sonicator
(Fisher Scientific). After centrifugation, supernatants containing
sheared chromatin were incubated for 4 h with 5 mg of anti–HIF-
1a antibody or IgG control (Upstate Biotechnology) as negative
control. Protein A sepharose was added and the incubation
continued overnight at 4uC. Immune complexes were washed
extensively and eluted from the protein A sepharose. The
supernatants were transferred to a new tube, and 1 mg/mlo f
RNase was added and incubated for 5 h at 67uC. Samples were
frozen at 280uC and 60 mg/ml proteinase K was added and
incubated for 2 h at 45uC. Next, DNA was purified and extracted
using Nucleo Spin Extract II kit (Macherey& Nagel, Dueren,
Germany) and analyzed by PCR. 1 ml of sample was used for each
PCR reaction. The sequences of the TLR2 and TLR6 promoter-
specific primers spanning the putative HIF-1–binding regions were
as follows. TLR2: sense, 59-TCAGCGCGAGGTCCAGAGTT -
39 and antisense, 59-TCCGAGCAGTCACCTGAGAG -39. The
size of the amplified product resulting from the use of this primer
pair was 320 bp. TLR6: sense, 59- AAGATGAGCCAGAGGT-
GAAG-39 and antisense, 59- GCAAGCAGCAGACACATCAA-
39. The size of the amplified product resulting from the use of this
primer pair was 285 bp. The primer sets were amplified using
increasing numbers of cycles of 94uC for 1 min, 56uC for 2 min,
72uC for 4 min, and a final extension of 72uC for 7 min. The PCR
transcripts were visualized on a 2% agarose gel containing 5 mg/
ml of ethidium bromide.
In vivo hypoxia model and immunohistochemistry
Colonic mucosal scraping (enriched in epithelial cells) were
obtained from 6–8 wk-old conditional HIF-1a mutant mice or
Table 1. Human and murine Primer pairs as used for real-time RT-PCR.
..................................................................................................................................................
Human Forward (59-39) Reverse (59-39) Product [bp] Temp [Cu]
ß-actin GGTGGCTTTTAGGATGGCAAG ACTGGAACGGTGAAGGTGACAG 161 58–61
TLR2 GGAGCTGAAGAACTTCAATC TTGCACCACTCACTCTTC 159 58
TLR6 CAGAGTGAGTGGTGCCATTA GCCTTCAGCTTGTGGTACTT 137 61
TLR10 AGGTGCAGTGGCTCACTCTT TTCACCATGTTGGCCAGGAT 100 58
Murine Forward (59-39) Reverse (59-39) Product [bp] Temp [Cu]
ß-actin CGAGCGTGGCTACAGCTTCA AGGAAGAGGATGCGGCAGTG 122 58–60
TLR1 TGATCTTGTGCCACCCAACA GCAGGGCATCAAAGGCATTA 66 58
TLR2 TTGCTCCTGCGAACTCCTAT AGCCTGGTGACATTCCAAGA 157 58
TLR3 TAGACTGCATCGCCTGCTAA AAGCAGCCAGAAGCAGAACT 122 59
TLR4 TCCGGAAGTTCACATAGCTG TCCATCTCACAAGGCATGTC 163 58
TLR5 AGCTGGTGTTCAAGGACAAG CCTGGATGTTGGAGATATGG 210 57
TLR6 TCTGGGATAGCCTCTGCAACA GGCGCAAACAAAGTGGAAAC 71 60
TLR7 TACCAGGACAGCCAGTTCTA AGGAGCCTCTGATGAGACAA 136 58
TLR8 TGCGCTACCACCTTGAAGAG CACTGGTTCCAGGAGGATGA 248 58
TLR9 ACCTCAGCCACAACATTCTC TGCACCTCCAACAGTAAGTC 142 58
TLR11 GGCAGAGGCTCCATAGTTAC CCGTCTCTTCAGTTGCTCAC 116 58
TLR12 CGCTTATGTCCAGGACAAGA GAGGAGAGGCAAGCCAATTA 144 58
TLR13 AGCCTAGCTGCCTGGAAGAA AGCTCAACAGGATGGAGAGT 100 58
doi:10.1371/journal.pone.0001364.t001
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PLoS ONE | www.plosone.org 10 December 2007 | Issue 12 | e1364littermate controls, as described previously [31]. Organs were
obtained from C57BL/6 mice exposed either to normobaric
hypoxia (8% O2 and 92% N2) or room temperature air for 6 h
(n=6 animals per condition). After hypoxia/normoxia exposure,
the animals were killed and organs were harvested. For RT-PCR
analysis scrapings and organs tissue were homogenized in
RNAlater (QUIAGEN) using a 22-gauge syringe (Becton-Dick-
inson) and Quiashredder column (QUIAGEN). Further analysis of
TLR2 and TLR6 mRNA fold changes were performed as
described above. For immunohistochemistry organs were harvest-
ed and collected in a tube containing Tissue Tec freezing media
and were then subsequently shock frozen. Frozen tissue were cut to
5-mm sections and placed on a glas slide. After fixation with
acetone for 10 min and washing in PBS for 10 min sections were
blocked in TBST supplemented with 0.05% Tween 20 and 5% of
human serum at room temperature for 30 min. After blocking
sections were incubated either with monoclonal mouse anti-TLR2
(eBioscience, 1:50–1:200 dilutions), or with polyclonal goat anti
TLR6 (Santa Cruz Biotechnology Inc., 1:50–1:200 dilutions) in
PBS-T supplemented with 0,05% Tween 20 and 5% of human
serum for 1 h at room temperature, followed by washing twice in
PBS. Alexa Fluor 488-conjugated goat anti-mouse (TLR2 and
IgG) or donkey anti-goat (TLR6) were used as secondary
antibodies (Invitrogen, 1:5000 for 60 min at room temperature).
After washing twice with PBS samples were mounted (ProLong
Gold antifade reagent, Invitrogen) and assessed within the next
24 h using a laser-scanning confocal microscope (Leica). Single-
plane optical slices were then processed for double-labelled cells
using identical laser and standardized microscope settings and
exported to Adobe Photoshop 5.0LE (TIFF). Representative
results are shown for the experiment for each condition. These
protocols were in accordance with National Institutes of Health
guidelines for use of live animals and were approved by the
Institutional Animal Care and Use Committee at University of
Colorado Health Science Center in Denver.
Data analysis
Data were compared by 2-factor ANOVA or Student’s t test,
where appropriate. Values are expressed as the mean6SEM from
at least three separate experiments per condition. P,0.05 was
considered statistically significant.
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